CAncer Risk and INsulin analoGues (CARING)

The CARING consortium has been formed to quantify the risk of cancer associated with the (long-term) use of insulin and insulin analogues. The seven partners of CARING are: - Utrecht University (Netherlands)- Aarhus University Hospital – Aarhus Sygehus (Denmark)- Norwegian Institute of Public Health (Norway) - Karolinska Institutet (Sweden)- University of Tampere (Finland) - University of Helsinki (Finland) - Netherlands Cancer Institute (Netherlands)